Manas AI, a full-stack, AI native drug discovery and development company, has announced the closing of a $26M Seed Extension and the addition of its new Co-Founder and Chief Technology Officer, Ujjwal Singh.

Manas AI's Seed Extension follows a $24.6M Seed Round announced in January of this year led by General Catalyst and Reid Hoffman. The seed extension also includes The General Partnership, Wisdom Ventures, Blitzscaling Ventures, Westbound Equity Partners, Mosaic Ventures, and a number of individuals.

Co-founded by Dr. Siddhartha Mukherjee, Reid Hoffman, and Ujjwal Singh, Manas AI builds and uses neuro-symbolic, science-based foundational models to discover and bring transformative medicines to market.